The Discounted Cash Flow (DCF) valuation of Pacira Biosciences Inc (PCRX) is (42.68) USD. With the latest stock price at 26.51 USD, the upside of Pacira Biosciences Inc based on DCF is -261.0%.
Based on the latest price of 26.51 USD and our DCF valuation, Pacira Biosciences Inc (PCRX) is a sell. selling PCRX stocks now will result in a potential gain of 261.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.2% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (189.35) - (27.22) | (42.68) |
| Upside | -814.3% - -202.7% | -261.0% |